MedTrace Logo

Clinical Trial for a Outpatient Clinical Management for Complicated Acute Appendicitis

NCT06059365 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2023-09-28

No results posted yet for this study

Summary

The aim of this study is to evaluate the safety and efficacy of outpatient management of complicated acute appendicitis. For this purpose, a randomized clinical trial was designed. Selected patients who have undergone surgery for acute appendicitis are randomized into two groups. One group with hospitalization and another group without admission.

Conditions

  • Acute Appendicitis
  • Appendicitis Perforated
  • Appendicitis Suppurative

Interventions

BEHAVIORAL

Hospitalization

Once the patient was operated and an uncomplicated appendicitis was confirmed, the patient was randomized to one of the two experimental branches: the hospitalization group (HG) or outpatient group (OG). In this group, were admitted in the hospitalization ward

BEHAVIORAL

Outpatient

Once the patient was operated and an uncomplicated appendicitis was confirmed, the patient was randomized to one of the two experimental branches: the hospitalization group (HG) or outpatient group (OG). Patients in the OG were referred to the day- surgery unit where they were discharged according to ALDRETE criteria.

Sponsors & Collaborators

  • Hospital Universitari Joan XXIII de Tarragona.

    collaborator OTHER

  • HJ23

    lead INDUSTRY

Principal Investigators

  • Jordi Elvira Lopez, MD, PhD · HJ23

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2023-11-01
Completion
2023-11-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06059365 on ClinicalTrials.gov